Expert review of clinical pharmacology
The efficacy and safety of indobufen versus aspirin in patients with acute myocardial infarction: a retrospective observational study.
Bryan Richard Sasmita, Linfeng Xie, Yuanzhu Li, Zhu Li, Siyuan Xie, Suxin Luo
Published: 202610.1080/17512433.2025.2611291
Abstract
BACKGROUND: Dual antiplatelet therapy with aspirin and P2Y12 inhibitors is the first antiplatelet of choice for acute myocardial infarction (AMI), but alternatives are needed for patients at high bleeding risk or with aspirin intolerance/hypersensiti…
Preview only. Read the full abstract at the source